| Record Information |
|---|
| Version | 5.0 |
|---|
| Status | Expected but not Quantified |
|---|
| Creation Date | 2012-09-06 15:16:49 UTC |
|---|
| Update Date | 2022-03-07 02:51:40 UTC |
|---|
| HMDB ID | HMDB0014583 |
|---|
| Secondary Accession Numbers | |
|---|
| Metabolite Identification |
|---|
| Common Name | Trimethoprim |
|---|
| Description | Trimethoprim, also known as proloprim or trimpex, belongs to the class of organic compounds known as anisoles. These are organic compounds containing a methoxybenzene or a derivative thereof. Trimethoprim is a very strong basic compound (based on its pKa). An aminopyrimidine antibiotic whose structure consists of pyrimidine 2,4-diamine and 1,2,3-trimethoxybenzene moieties linked by a methylene bridge. |
|---|
| Structure | COC1=CC(CC2=CN=C(N)N=C2N)=CC(OC)=C1OC InChI=1S/C14H18N4O3/c1-19-10-5-8(6-11(20-2)12(10)21-3)4-9-7-17-14(16)18-13(9)15/h5-7H,4H2,1-3H3,(H4,15,16,17,18) |
|---|
| Synonyms | | Value | Source |
|---|
| 2,4-Diamino-5-(3,4,5-trimethoxybenzyl)pyrimidine | ChEBI | | 5-[(3,4,5-Trimethoxyphenyl)methyl]-2,4-pyrimidinediamine | ChEBI | | Proloprim | ChEBI | | Trimpex | ChEBI | | CO-Trimoxazole | HMDB |
|
|---|
| Chemical Formula | C14H18N4O3 |
|---|
| Average Molecular Weight | 290.3177 |
|---|
| Monoisotopic Molecular Weight | 290.137890462 |
|---|
| IUPAC Name | 5-[(3,4,5-trimethoxyphenyl)methyl]pyrimidine-2,4-diamine |
|---|
| Traditional Name | trimethoprim |
|---|
| CAS Registry Number | 738-70-5 |
|---|
| SMILES | COC1=CC(CC2=CN=C(N)N=C2N)=CC(OC)=C1OC |
|---|
| InChI Identifier | InChI=1S/C14H18N4O3/c1-19-10-5-8(6-11(20-2)12(10)21-3)4-9-7-17-14(16)18-13(9)15/h5-7H,4H2,1-3H3,(H4,15,16,17,18) |
|---|
| InChI Key | IEDVJHCEMCRBQM-UHFFFAOYSA-N |
|---|
| Chemical Taxonomy |
|---|
| Description | Belongs to the class of organic compounds known as anisoles. These are organic compounds containing a methoxybenzene or a derivative thereof. |
|---|
| Kingdom | Organic compounds |
|---|
| Super Class | Benzenoids |
|---|
| Class | Phenol ethers |
|---|
| Sub Class | Anisoles |
|---|
| Direct Parent | Anisoles |
|---|
| Alternative Parents | |
|---|
| Substituents | - Phenoxy compound
- Anisole
- Methoxybenzene
- Alkyl aryl ether
- Aminopyrimidine
- Monocyclic benzene moiety
- Pyrimidine
- Imidolactam
- Heteroaromatic compound
- Organoheterocyclic compound
- Ether
- Azacycle
- Organic oxygen compound
- Amine
- Primary amine
- Organooxygen compound
- Organonitrogen compound
- Organic nitrogen compound
- Organopnictogen compound
- Hydrocarbon derivative
- Aromatic heteromonocyclic compound
|
|---|
| Molecular Framework | Aromatic heteromonocyclic compounds |
|---|
| External Descriptors | |
|---|
| Ontology |
|---|
| Physiological effect | Not Available |
|---|
| Disposition | |
|---|
| Process | Not Available |
|---|
| Role | Not Available |
|---|
| Physical Properties |
|---|
| State | Solid |
|---|
| Experimental Molecular Properties | | Property | Value | Reference |
|---|
| Melting Point | 199 - 203 °C | Not Available | | Boiling Point | Not Available | Not Available | | Water Solubility | 0.62 g/L | Not Available | | LogP | 0.6 | Not Available |
|
|---|
| Experimental Chromatographic Properties | Experimental Collision Cross Sections |
|---|
| Predicted Molecular Properties | |
|---|
| Predicted Chromatographic Properties | Predicted Collision Cross SectionsPredicted Retention Times Underivatized| Chromatographic Method | Retention Time | Reference |
|---|
| Measured using a Waters Acquity ultraperformance liquid chromatography (UPLC) ethylene-bridged hybrid (BEH) C18 column (100 mm × 2.1 mm; 1.7 μmparticle diameter). Predicted by Afia on May 17, 2022. Predicted by Afia on May 17, 2022. | 2.12 minutes | 32390414 | | Predicted by Siyang on May 30, 2022 | 9.9937 minutes | 33406817 | | Predicted by Siyang using ReTip algorithm on June 8, 2022 | 2.98 minutes | 32390414 | | AjsUoB = Accucore 150 Amide HILIC with 10mM Ammonium Formate, 0.1% Formic Acid | 36.0 seconds | 40023050 | | Fem_Long = Waters ACQUITY UPLC HSS T3 C18 with Water:MeOH and 0.1% Formic Acid | 646.9 seconds | 40023050 | | Fem_Lipids = Ascentis Express C18 with (60:40 water:ACN):(90:10 IPA:ACN) and 10mM NH4COOH + 0.1% Formic Acid | 209.1 seconds | 40023050 | | Life_Old = Waters ACQUITY UPLC BEH C18 with Water:(20:80 acetone:ACN) and 0.1% Formic Acid | 124.9 seconds | 40023050 | | Life_New = RP Waters ACQUITY UPLC HSS T3 C18 with Water:(30:70 MeOH:ACN) and 0.1% Formic Acid | 164.3 seconds | 40023050 | | RIKEN = Waters ACQUITY UPLC BEH C18 with Water:ACN and 0.1% Formic Acid | 62.8 seconds | 40023050 | | Eawag_XBridgeC18 = XBridge C18 3.5u 2.1x50 mm with Water:MeOH and 0.1% Formic Acid | 282.6 seconds | 40023050 | | BfG_NTS_RP1 =Agilent Zorbax Eclipse Plus C18 (2.1 mm x 150 mm, 3.5 um) with Water:ACN and 0.1% Formic Acid | 350.9 seconds | 40023050 | | HILIC_BDD_2 = Merck SeQuant ZIC-HILIC with ACN(0.1% formic acid):water(16 mM ammonium formate) | 392.3 seconds | 40023050 | | UniToyama_Atlantis = RP Waters Atlantis T3 (2.1 x 150 mm, 5 um) with ACN:Water and 0.1% Formic Acid | 717.6 seconds | 40023050 | | BDD_C18 = Hypersil Gold 1.9µm C18 with Water:ACN and 0.1% Formic Acid | 196.2 seconds | 40023050 | | UFZ_Phenomenex = Kinetex Core-Shell C18 2.6 um, 3.0 x 100 mm, Phenomenex with Water:MeOH and 0.1% Formic Acid | 798.8 seconds | 40023050 | | SNU_RIKEN_POS = Waters ACQUITY UPLC BEH C18 with Water:ACN and 0.1% Formic Acid | 210.5 seconds | 40023050 | | RPMMFDA = Waters ACQUITY UPLC BEH C18 with Water:ACN and 0.1% Formic Acid | 246.2 seconds | 40023050 | | MTBLS87 = Merck SeQuant ZIC-pHILIC column with ACN:Water and :ammonium carbonate | 412.9 seconds | 40023050 | | KI_GIAR_zic_HILIC_pH2_7 = Merck SeQuant ZIC-HILIC with ACN:Water and 0.1% FA | 243.6 seconds | 40023050 | | Meister zic-pHILIC pH9.3 = Merck SeQuant ZIC-pHILIC column with ACN:Water 5mM NH4Ac pH9.3 and 5mM ammonium acetate in water | 20.3 seconds | 40023050 |
Predicted Kovats Retention IndicesUnderivatizedDerivatized| Derivative Name / Structure | SMILES | Kovats RI Value | Column Type | Reference |
|---|
| Trimethoprim,1TMS,isomer #1 | COC1=CC(CC2=CN=C(N[Si](C)(C)C)N=C2N)=CC(OC)=C1OC | 2666.2 | Semi standard non polar | 33892256 | | Trimethoprim,1TMS,isomer #1 | COC1=CC(CC2=CN=C(N[Si](C)(C)C)N=C2N)=CC(OC)=C1OC | 2610.4 | Standard non polar | 33892256 | | Trimethoprim,1TMS,isomer #1 | COC1=CC(CC2=CN=C(N[Si](C)(C)C)N=C2N)=CC(OC)=C1OC | 4269.8 | Standard polar | 33892256 | | Trimethoprim,1TMS,isomer #2 | COC1=CC(CC2=CN=C(N)N=C2N[Si](C)(C)C)=CC(OC)=C1OC | 2679.4 | Semi standard non polar | 33892256 | | Trimethoprim,1TMS,isomer #2 | COC1=CC(CC2=CN=C(N)N=C2N[Si](C)(C)C)=CC(OC)=C1OC | 2606.6 | Standard non polar | 33892256 | | Trimethoprim,1TMS,isomer #2 | COC1=CC(CC2=CN=C(N)N=C2N[Si](C)(C)C)=CC(OC)=C1OC | 4121.0 | Standard polar | 33892256 | | Trimethoprim,2TMS,isomer #1 | COC1=CC(CC2=CN=C(N[Si](C)(C)C)N=C2N[Si](C)(C)C)=CC(OC)=C1OC | 2632.7 | Semi standard non polar | 33892256 | | Trimethoprim,2TMS,isomer #1 | COC1=CC(CC2=CN=C(N[Si](C)(C)C)N=C2N[Si](C)(C)C)=CC(OC)=C1OC | 2623.0 | Standard non polar | 33892256 | | Trimethoprim,2TMS,isomer #1 | COC1=CC(CC2=CN=C(N[Si](C)(C)C)N=C2N[Si](C)(C)C)=CC(OC)=C1OC | 4011.1 | Standard polar | 33892256 | | Trimethoprim,2TMS,isomer #2 | COC1=CC(CC2=CN=C(N([Si](C)(C)C)[Si](C)(C)C)N=C2N)=CC(OC)=C1OC | 2599.1 | Semi standard non polar | 33892256 | | Trimethoprim,2TMS,isomer #2 | COC1=CC(CC2=CN=C(N([Si](C)(C)C)[Si](C)(C)C)N=C2N)=CC(OC)=C1OC | 2659.9 | Standard non polar | 33892256 | | Trimethoprim,2TMS,isomer #2 | COC1=CC(CC2=CN=C(N([Si](C)(C)C)[Si](C)(C)C)N=C2N)=CC(OC)=C1OC | 3946.1 | Standard polar | 33892256 | | Trimethoprim,2TMS,isomer #3 | COC1=CC(CC2=CN=C(N)N=C2N([Si](C)(C)C)[Si](C)(C)C)=CC(OC)=C1OC | 2553.6 | Semi standard non polar | 33892256 | | Trimethoprim,2TMS,isomer #3 | COC1=CC(CC2=CN=C(N)N=C2N([Si](C)(C)C)[Si](C)(C)C)=CC(OC)=C1OC | 2709.4 | Standard non polar | 33892256 | | Trimethoprim,2TMS,isomer #3 | COC1=CC(CC2=CN=C(N)N=C2N([Si](C)(C)C)[Si](C)(C)C)=CC(OC)=C1OC | 3870.4 | Standard polar | 33892256 | | Trimethoprim,3TMS,isomer #1 | COC1=CC(CC2=CN=C(N([Si](C)(C)C)[Si](C)(C)C)N=C2N[Si](C)(C)C)=CC(OC)=C1OC | 2610.6 | Semi standard non polar | 33892256 | | Trimethoprim,3TMS,isomer #1 | COC1=CC(CC2=CN=C(N([Si](C)(C)C)[Si](C)(C)C)N=C2N[Si](C)(C)C)=CC(OC)=C1OC | 2621.2 | Standard non polar | 33892256 | | Trimethoprim,3TMS,isomer #1 | COC1=CC(CC2=CN=C(N([Si](C)(C)C)[Si](C)(C)C)N=C2N[Si](C)(C)C)=CC(OC)=C1OC | 3579.4 | Standard polar | 33892256 | | Trimethoprim,3TMS,isomer #2 | COC1=CC(CC2=CN=C(N[Si](C)(C)C)N=C2N([Si](C)(C)C)[Si](C)(C)C)=CC(OC)=C1OC | 2604.1 | Semi standard non polar | 33892256 | | Trimethoprim,3TMS,isomer #2 | COC1=CC(CC2=CN=C(N[Si](C)(C)C)N=C2N([Si](C)(C)C)[Si](C)(C)C)=CC(OC)=C1OC | 2674.5 | Standard non polar | 33892256 | | Trimethoprim,3TMS,isomer #2 | COC1=CC(CC2=CN=C(N[Si](C)(C)C)N=C2N([Si](C)(C)C)[Si](C)(C)C)=CC(OC)=C1OC | 3678.5 | Standard polar | 33892256 | | Trimethoprim,4TMS,isomer #1 | COC1=CC(CC2=CN=C(N([Si](C)(C)C)[Si](C)(C)C)N=C2N([Si](C)(C)C)[Si](C)(C)C)=CC(OC)=C1OC | 2649.8 | Semi standard non polar | 33892256 | | Trimethoprim,4TMS,isomer #1 | COC1=CC(CC2=CN=C(N([Si](C)(C)C)[Si](C)(C)C)N=C2N([Si](C)(C)C)[Si](C)(C)C)=CC(OC)=C1OC | 2655.1 | Standard non polar | 33892256 | | Trimethoprim,4TMS,isomer #1 | COC1=CC(CC2=CN=C(N([Si](C)(C)C)[Si](C)(C)C)N=C2N([Si](C)(C)C)[Si](C)(C)C)=CC(OC)=C1OC | 3287.5 | Standard polar | 33892256 | | Trimethoprim,1TBDMS,isomer #1 | COC1=CC(CC2=CN=C(N[Si](C)(C)C(C)(C)C)N=C2N)=CC(OC)=C1OC | 2853.9 | Semi standard non polar | 33892256 | | Trimethoprim,1TBDMS,isomer #1 | COC1=CC(CC2=CN=C(N[Si](C)(C)C(C)(C)C)N=C2N)=CC(OC)=C1OC | 2825.4 | Standard non polar | 33892256 | | Trimethoprim,1TBDMS,isomer #1 | COC1=CC(CC2=CN=C(N[Si](C)(C)C(C)(C)C)N=C2N)=CC(OC)=C1OC | 4235.7 | Standard polar | 33892256 | | Trimethoprim,1TBDMS,isomer #2 | COC1=CC(CC2=CN=C(N)N=C2N[Si](C)(C)C(C)(C)C)=CC(OC)=C1OC | 2873.4 | Semi standard non polar | 33892256 | | Trimethoprim,1TBDMS,isomer #2 | COC1=CC(CC2=CN=C(N)N=C2N[Si](C)(C)C(C)(C)C)=CC(OC)=C1OC | 2817.2 | Standard non polar | 33892256 | | Trimethoprim,1TBDMS,isomer #2 | COC1=CC(CC2=CN=C(N)N=C2N[Si](C)(C)C(C)(C)C)=CC(OC)=C1OC | 4105.2 | Standard polar | 33892256 | | Trimethoprim,2TBDMS,isomer #1 | COC1=CC(CC2=CN=C(N[Si](C)(C)C(C)(C)C)N=C2N[Si](C)(C)C(C)(C)C)=CC(OC)=C1OC | 3031.7 | Semi standard non polar | 33892256 | | Trimethoprim,2TBDMS,isomer #1 | COC1=CC(CC2=CN=C(N[Si](C)(C)C(C)(C)C)N=C2N[Si](C)(C)C(C)(C)C)=CC(OC)=C1OC | 3020.8 | Standard non polar | 33892256 | | Trimethoprim,2TBDMS,isomer #1 | COC1=CC(CC2=CN=C(N[Si](C)(C)C(C)(C)C)N=C2N[Si](C)(C)C(C)(C)C)=CC(OC)=C1OC | 3981.5 | Standard polar | 33892256 | | Trimethoprim,2TBDMS,isomer #2 | COC1=CC(CC2=CN=C(N([Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C)N=C2N)=CC(OC)=C1OC | 3033.6 | Semi standard non polar | 33892256 | | Trimethoprim,2TBDMS,isomer #2 | COC1=CC(CC2=CN=C(N([Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C)N=C2N)=CC(OC)=C1OC | 3086.2 | Standard non polar | 33892256 | | Trimethoprim,2TBDMS,isomer #2 | COC1=CC(CC2=CN=C(N([Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C)N=C2N)=CC(OC)=C1OC | 3916.1 | Standard polar | 33892256 | | Trimethoprim,2TBDMS,isomer #3 | COC1=CC(CC2=CN=C(N)N=C2N([Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C)=CC(OC)=C1OC | 2988.0 | Semi standard non polar | 33892256 | | Trimethoprim,2TBDMS,isomer #3 | COC1=CC(CC2=CN=C(N)N=C2N([Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C)=CC(OC)=C1OC | 3084.9 | Standard non polar | 33892256 | | Trimethoprim,2TBDMS,isomer #3 | COC1=CC(CC2=CN=C(N)N=C2N([Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C)=CC(OC)=C1OC | 3876.2 | Standard polar | 33892256 | | Trimethoprim,3TBDMS,isomer #1 | COC1=CC(CC2=CN=C(N([Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C)N=C2N[Si](C)(C)C(C)(C)C)=CC(OC)=C1OC | 3159.7 | Semi standard non polar | 33892256 | | Trimethoprim,3TBDMS,isomer #1 | COC1=CC(CC2=CN=C(N([Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C)N=C2N[Si](C)(C)C(C)(C)C)=CC(OC)=C1OC | 3230.2 | Standard non polar | 33892256 | | Trimethoprim,3TBDMS,isomer #1 | COC1=CC(CC2=CN=C(N([Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C)N=C2N[Si](C)(C)C(C)(C)C)=CC(OC)=C1OC | 3689.2 | Standard polar | 33892256 | | Trimethoprim,3TBDMS,isomer #2 | COC1=CC(CC2=CN=C(N[Si](C)(C)C(C)(C)C)N=C2N([Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C)=CC(OC)=C1OC | 3177.4 | Semi standard non polar | 33892256 | | Trimethoprim,3TBDMS,isomer #2 | COC1=CC(CC2=CN=C(N[Si](C)(C)C(C)(C)C)N=C2N([Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C)=CC(OC)=C1OC | 3220.9 | Standard non polar | 33892256 | | Trimethoprim,3TBDMS,isomer #2 | COC1=CC(CC2=CN=C(N[Si](C)(C)C(C)(C)C)N=C2N([Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C)=CC(OC)=C1OC | 3774.4 | Standard polar | 33892256 | | Trimethoprim,4TBDMS,isomer #1 | COC1=CC(CC2=CN=C(N([Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C)N=C2N([Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C)=CC(OC)=C1OC | 3362.7 | Semi standard non polar | 33892256 | | Trimethoprim,4TBDMS,isomer #1 | COC1=CC(CC2=CN=C(N([Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C)N=C2N([Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C)=CC(OC)=C1OC | 3434.3 | Standard non polar | 33892256 | | Trimethoprim,4TBDMS,isomer #1 | COC1=CC(CC2=CN=C(N([Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C)N=C2N([Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C)=CC(OC)=C1OC | 3533.9 | Standard polar | 33892256 |
|
|---|
| GC-MS Spectra| Spectrum Type | Description | Splash Key | Deposition Date | Source | View |
|---|
| Experimental GC-MS | GC-MS Spectrum - Trimethoprim EI-B (Non-derivatized) | splash10-0006-5390000000-e68103f64cbb997e5776 | 2017-09-12 | HMDB team, MONA, MassBank | View Spectrum | | Experimental GC-MS | GC-MS Spectrum - Trimethoprim EI-B (Non-derivatized) | splash10-0006-5390000000-e68103f64cbb997e5776 | 2018-05-18 | HMDB team, MONA, MassBank | View Spectrum | | Predicted GC-MS | Predicted GC-MS Spectrum - Trimethoprim GC-MS (Non-derivatized) - 70eV, Positive | splash10-072c-0390000000-14ead3ead386e06ae454 | 2017-09-01 | Wishart Lab | View Spectrum | | Predicted GC-MS | Predicted GC-MS Spectrum - Trimethoprim GC-MS (Non-derivatized) - 70eV, Positive | Not Available | 2021-10-12 | Wishart Lab | View Spectrum |
MS/MS Spectra| Spectrum Type | Description | Splash Key | Deposition Date | Source | View |
|---|
| Experimental LC-MS/MS | LC-MS/MS Spectrum - Trimethoprim LC-ESI-qTof , Positive-QTOF | splash10-03na-2690000000-39babdc7b45a0aa0adf7 | 2017-09-14 | HMDB team, MONA | View Spectrum | | Experimental LC-MS/MS | LC-MS/MS Spectrum - Trimethoprim LC-ESI-ITFT , positive-QTOF | splash10-0089-0290000000-32000410829186ca112c | 2017-09-14 | HMDB team, MONA | View Spectrum | | Experimental LC-MS/MS | LC-MS/MS Spectrum - Trimethoprim LC-ESI-ITFT , positive-QTOF | splash10-0006-0090000000-44ccaa9725303a7db8a4 | 2017-09-14 | HMDB team, MONA | View Spectrum | | Experimental LC-MS/MS | LC-MS/MS Spectrum - Trimethoprim LC-ESI-ITFT , positive-QTOF | splash10-0006-0090000000-af77a44791c8867aad66 | 2017-09-14 | HMDB team, MONA | View Spectrum | | Experimental LC-MS/MS | LC-MS/MS Spectrum - Trimethoprim LC-ESI-ITFT , positive-QTOF | splash10-0006-0190000000-8eb1449e3f800368c863 | 2017-09-14 | HMDB team, MONA | View Spectrum | | Experimental LC-MS/MS | LC-MS/MS Spectrum - Trimethoprim LC-ESI-ITFT , positive-QTOF | splash10-03n9-0190000000-deb1664d211c2227b048 | 2017-09-14 | HMDB team, MONA | View Spectrum | | Experimental LC-MS/MS | LC-MS/MS Spectrum - Trimethoprim LC-ESI-ITFT , positive-QTOF | splash10-077i-0590000000-ae48b54f4879c1551670 | 2017-09-14 | HMDB team, MONA | View Spectrum | | Experimental LC-MS/MS | LC-MS/MS Spectrum - Trimethoprim LC-ESI-ITFT , positive-QTOF | splash10-0089-1950000000-5084ea4b328a585b675d | 2017-09-14 | HMDB team, MONA | View Spectrum | | Experimental LC-MS/MS | LC-MS/MS Spectrum - Trimethoprim LC-ESI-ITFT , positive-QTOF | splash10-0006-0090000000-fb9fa4e4130917b6e6ff | 2017-09-14 | HMDB team, MONA | View Spectrum | | Experimental LC-MS/MS | LC-MS/MS Spectrum - Trimethoprim LC-ESI-ITFT , positive-QTOF | splash10-0006-0090000000-15d83f92b30f466cd587 | 2017-09-14 | HMDB team, MONA | View Spectrum | | Experimental LC-MS/MS | LC-MS/MS Spectrum - Trimethoprim LC-ESI-ITFT , positive-QTOF | splash10-0006-0190000000-f95e0c038a6aa70dc02e | 2017-09-14 | HMDB team, MONA | View Spectrum | | Experimental LC-MS/MS | LC-MS/MS Spectrum - Trimethoprim LC-ESI-ITFT , positive-QTOF | splash10-03na-0190000000-72c88d8f9739c7d29714 | 2017-09-14 | HMDB team, MONA | View Spectrum | | Experimental LC-MS/MS | LC-MS/MS Spectrum - Trimethoprim LC-ESI-ITFT , positive-QTOF | splash10-077i-0590000000-9c0f5662b9713adab9cb | 2017-09-14 | HMDB team, MONA | View Spectrum | | Experimental LC-MS/MS | LC-MS/MS Spectrum - Trimethoprim LC-ESI-ITFT , positive-QTOF | splash10-0089-1950000000-8b16041ba3b127d299ba | 2017-09-14 | HMDB team, MONA | View Spectrum | | Experimental LC-MS/MS | LC-MS/MS Spectrum - Trimethoprim LC-ESI-ITFT , positive-QTOF | splash10-0089-0290000000-6a16da6c03a03fd87f34 | 2017-09-14 | HMDB team, MONA | View Spectrum | | Experimental LC-MS/MS | LC-MS/MS Spectrum - Trimethoprim LC-ESI-QQ , positive-QTOF | splash10-0006-0090000000-145bf44afce31ab82f64 | 2017-09-14 | HMDB team, MONA | View Spectrum | | Experimental LC-MS/MS | LC-MS/MS Spectrum - Trimethoprim LC-ESI-QQ , positive-QTOF | splash10-0006-0090000000-68ca013641f0c338b3a2 | 2017-09-14 | HMDB team, MONA | View Spectrum | | Experimental LC-MS/MS | LC-MS/MS Spectrum - Trimethoprim LC-ESI-QQ , positive-QTOF | splash10-008c-0290000000-d56028ecf88d373b83bd | 2017-09-14 | HMDB team, MONA | View Spectrum | | Experimental LC-MS/MS | LC-MS/MS Spectrum - Trimethoprim LC-ESI-QQ , positive-QTOF | splash10-03n9-0590000000-15246e14a33089adf87d | 2017-09-14 | HMDB team, MONA | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Trimethoprim 10V, Positive-QTOF | splash10-0006-0090000000-ab604617a206ca211558 | 2016-06-03 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Trimethoprim 20V, Positive-QTOF | splash10-006x-0190000000-20fc4fb0fdca747b84f8 | 2016-06-03 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Trimethoprim 40V, Positive-QTOF | splash10-00dj-3690000000-0ec38b6068b0db0dfb83 | 2016-06-03 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Trimethoprim 10V, Negative-QTOF | splash10-000i-0090000000-8e413946db77cf7ccfea | 2016-08-03 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Trimethoprim 20V, Negative-QTOF | splash10-000i-1090000000-691ddb4fa4a66277fa2e | 2016-08-03 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Trimethoprim 40V, Negative-QTOF | splash10-0006-7390000000-a01859f18f535ce1b096 | 2016-08-03 | Wishart Lab | View Spectrum |
|
|---|